Showing 1 - 5 of 5
As many more clinical trials collect economic information within their study design, so health economics analysts are increasingly working with patient-level data on both costs and effects. In this paper, we review recent advances in the use of statistical methods for economic analysis of...
Persistent link: https://www.econbiz.de/10009455448
Four different types of evaluation methods, cost-benefit analysis (CBA), cost-utility analysis (CUA), cost-effectiveness analysis (CEA) and cost-minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by showing the rare circumstances under...
Persistent link: https://www.econbiz.de/10009455449
The principal object of the study, set out in Dr. Dejardin's model report of 1st February 1979. is to quantify the factors influEmcing the annual growth in public expenditure between 1970 and 1976 on the following services: general medical care. specialist medical care (excluding in-patient...
Persistent link: https://www.econbiz.de/10009455793
Background: There is a growing recognition of the importance of introducing new ways of working into the UK?s National Health Service (NHS) and other health systems, in order to ensure that patient care is provided as effectively and efficiently as possible. Researchers have examined the...
Persistent link: https://www.econbiz.de/10009485375
Direct patient care requires knowledge sharing between clinical professionals. However, clinicians have often been suspicious of managers' motives, this lack of trust often resulting in reluctance to share knowledge for managerial purposes. Trust is one component of the psychological contract -...
Persistent link: https://www.econbiz.de/10009485422